Our Latest News
August 29, 2024
Our Planet Care Strategy: Concrete Actions Towards Net Zero Emissions
Presenting our 2023 ESG Report
In Chapter 3 of the French Universal Registration Document (Declaration of Extra-financial Performance), we share our progress on our embedded CSR strategy for 2023.
Environmental, Social and Governance Performance
ESG and commercial considerations are intrinsically linked and ongoing progress in our ESG performance is vital for Sanofi to succeed and grow in a sustainable way.
Leading the Way for Sustainable Finance
Sanofi is a pioneer of sustainable finance, with two Sustainability-linked Revolving Credit Facilities since 2020 and a Sustainability-Linked Bond, linked to its Global Health Unit, since 2021.
Product litigations
Information on Sodium Valproate (Depakine)
Information on Dengvaxia®
For most recent ESG information, see also our:
Quarterly results
ESG information throughout the quarterly results presentations and in the quarterly press releases
ESG quarterly update
We have compiled the latest ESG topic and ESG KPIS presented during the earnings call to ensure they are easily accessible for the financial community.
ESG report
In Chapter 3 of the French Universal Registration Document (Declaration of Extra-financial Performance), we share our progress on our embedded CSR strategy for 2023.
ESG Key Performance Indicators (Excel)
See our key ESG Performance Indicators
Global Reporting initiative (GRI) Index
See our GRI Index table
Sustainability Accounting Standards Board (SASB) index
See our SASB Index table
Our US Prescription Medicine Pricing Principles
We work passionately to prevent, treat and cure illness and disease, understand and solve healthcare needs of people across the world, and transform the practice of medicine.